GSK-114( GSK114 )

Catalog No. M11212 CAS No. 1301761-96-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

GSK-114
Note

Research use only, not for human use.
Brief Description

GSK-114 is a potent, selective TNNI3K inhibitor with IC50 of 25 nM.
Description

GSK-114 is a potent, selective TNNI3K inhibitor with IC50 of 25 nM, dispalys 40-fold over B-Raf, exceptional broad spectrum kinase selectivity (IC50>1,000 nM, 99% of kinases, 291/294); has adequate oral exposure to enable its use in cellular and in vivo studies.
In Vitro

At a concentration of 1 μM, GSK114 demonstrated an affinity for seven other kinases: ACK1, B-Raf, GAK, MEK5, PDGFRB, STK36, and ZAK.
In Vivo

GSK-114 affords the best balance of specificity and pharmacokinetics, demonstrating useful oral exposure (poDNAUC=0.18, Cmax=130 ng/ml @ 2 mg/kg, t1/2=3.6 hr, rat Fu=20.2%).
Synonyms

GSK114
Pathway

MAPK/ERK Signaling
Target

MEK
Recptor

MEK
Research Area

——
Indication

——

CAS Number

1301761-96-5
Formula Weight

417.484
Molecular Formula

C19H23N5O4S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 5.95 mg/mL (14.25 mM)
SMILES

O=S(C1=CC=C(N(C)C)C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)=C1)(NC)=O
Chemical Name

3-((6,7-dimethoxyquinazolin-4-yl)amino)-4-(dimethylamino)-N-methylbenzenesulfonamide

1. Lawhorn BG, et al. Bioorg Med Chem Lett. 2016 Jul 15;26(14):3355-8.

Calculator

molnova catalog